# Generics Sector

Canonical URL: https://biopharmsignal.com/sector/generics

Generics includes companies whose business depends heavily on off-patent drug competition, manufacturing execution, and product portfolio breadth. This category is less about a single pipeline event and more about launch timing, pricing, and operational discipline.

Companies currently grouped under Generics: 8

## Recent Sector News

- 2026-09-03 10:55 EST — ANIP — [ANI Pharmaceuticals to Present at September Investor Conferences](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-to-present-at-september-investor-conferences-9c102b8f) — Source: ANI Pharmaceuticals
- 2026-08-31 13:30 EST — CHRS — [Coherus to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/CHRS/coherus-to-participate-in-upcoming-investor-conferences-2fec3539) — Source: Coherus BioSciences, Inc.
- 2026-08-31 08:30 EST — ALVO — [Matvæla- og lyfjastofnun Bandaríkjanna (FDA) tekur til afgreiðslu umsókn Alvotech um markaðsleyfi fyrir fyrirhugaða hliðstæðu við Entyvio í sprautu eða lyfjapenna](https://biopharmsignal.com/news/ALVO/matv-la-og-lyfjastofnun-bandar-kjanna-fda-tekur-til-afgrei-slu-ums-kn-alvotech-u-77ce200e) — Source: Alvotech
- 2026-08-31 08:30 EST — ALVO — [Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations](https://biopharmsignal.com/news/ALVO/alvotech-announces-fda-acceptance-for-review-of-biologics-license-application-fo-e9b4232d) — Source: Alvotech
- 2026-08-27 12:00 EST — ALVO — [Alvotech tekur þátt í ráðstefnum fyrir fjárfesta í september](https://biopharmsignal.com/news/ALVO/alvotech-tekur-tt-r-stefnum-fyrir-fj-rfesta-september-d70fb244) — Source: Alvotech
- 2026-08-27 12:00 EST — ALVO — [Alvotech to present at upcoming investor conferences in September](https://biopharmsignal.com/news/ALVO/alvotech-to-present-at-upcoming-investor-conferences-in-september-6db07c4b) — Source: Alvotech
- 2026-08-24 10:55 EST — ANIP — [ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-appoints-henry-gosebruch-to-board-of-directors-98e272ac) — Source: ANI Pharmaceuticals
- 2026-08-21 13:00 EST — ALVO — [Alvotech kynnir samning við Lotus Pharmaceutical um markaðssetningu á fyrirhuguðum hliðstæðum við durvalumab og emicizumab í Bandaríkjunum og á völdum mörkuðum í Asíu](https://biopharmsignal.com/news/ALVO/alvotech-kynnir-samning-vi-lotus-pharmaceutical-um-marka-ssetningu-fyrirhugu-um--6c472154) — Source: Alvotech
- 2026-08-21 13:00 EST — ALVO — [Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets](https://biopharmsignal.com/news/ALVO/alvotech-announces-licensing-and-commercialization-agreement-with-lotus-pharmace-f7cce9ee) — Source: Alvotech
- 2026-08-19 20:30 EST — ALVO — [Alvotech birtir árshlutauppgjör fyrir fyrstu sex mánuði ársins 2026](https://biopharmsignal.com/news/ALVO/alvotech-birtir-rshlutauppgj-r-fyrir-fyrstu-sex-m-nu-i-rsins-2026-e490fdc4) — Source: Alvotech
- 2026-08-19 20:30 EST — ALVO — [Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update](https://biopharmsignal.com/news/ALVO/alvotech-announces-financial-results-for-the-first-half-of-2026-and-provides-a-b-d72d927d) — Source: Alvotech
- 2026-08-17 21:33 EST — CHRS — [Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights](https://biopharmsignal.com/news/CHRS/coherus-oncology-announces-special-dividend-of-biosimilar-contingent-value-right-b0dca6eb) — Source: Coherus BioSciences, Inc.
- 2026-08-10 12:00 EST — ALVO — [Alvotech birtir uppgjör fyrri árshelmings 2026 þann 19. ágúst nk.](https://biopharmsignal.com/news/ALVO/alvotech-birtir-uppgj-r-fyrri-rshelmings-2026-ann-19-g-st-nk-5afe914b) — Source: Alvotech
- 2026-08-10 12:00 EST — ALVO — [Alvotech to Report Financial Results for H1 2026](https://biopharmsignal.com/news/ALVO/alvotech-to-report-financial-results-for-h1-2026-2c4a0d3c) — Source: Alvotech
- 2026-08-10 12:00 EST — AMRX — [Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader](https://biopharmsignal.com/news/AMRX/amneal-completes-acquisition-of-kashiv-biosciences-creating-a-global-biosimilar--72e33362) — Source: Amneal Pharmaceuticals
- 2026-08-07 10:50 EST — ANIP — [ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-reports-record-second-quarter-2026-financial-results-68f15c4b) — Source: ANI Pharmaceuticals
- 2026-08-05 20:28 EST — CHRS — [Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/CHRS/coherus-oncology-reports-second-quarter-2026-financial-results-and-provides-busi-6d46d16c) — Source: Coherus BioSciences, Inc.
- 2026-07-30 10:00 EST — AMRX — [Amneal Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/AMRX/amneal-reports-second-quarter-2026-financial-results-43ee7ea0) — Source: Amneal Pharmaceuticals
- 2026-07-29 13:32 EST — ALVO — [Alvotech tilkynnir að Matvæla- og lyfjaeftirlit Bandaríkjanna (FDA) hefur lokið úttekt sinni á framleiðsluaðstöðu félagsins](https://biopharmsignal.com/news/ALVO/alvotech-tilkynnir-a-matv-la-og-lyfjaeftirlit-bandar-kjanna-fda-hefur-loki-ttekt-ebe2b467) — Source: Alvotech
- 2026-07-29 13:32 EST — ALVO — [Alvotech announces successful closure of FDA inspection of manufacturing facility](https://biopharmsignal.com/news/ALVO/alvotech-announces-successful-closure-of-fda-inspection-of-manufacturing-facilit-f9dda4fa) — Source: Alvotech

## Companies

- [ALVO](https://biopharmsignal.com/company/ALVO) — Alvotech
- [AMGN](https://biopharmsignal.com/company/AMGN) — Amgen Inc.
- [AMRX](https://biopharmsignal.com/company/AMRX) — Amneal Pharmaceuticals
- [ANIP](https://biopharmsignal.com/company/ANIP) — ANI Pharmaceuticals
- [CHRS](https://biopharmsignal.com/company/CHRS) — Coherus BioSciences, Inc.
- [RDY](https://biopharmsignal.com/company/RDY) — Dr. Reddy's Laboratories Ltd
- [SNY](https://biopharmsignal.com/company/SNY) — Sanofi
- [VTRS](https://biopharmsignal.com/company/VTRS) — Viatris Inc.